| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Dexcel Pharma Technologies Ltd. | 10%+ Owner | $5.13M | Jun 2, 2021 | ||
| Dror Bashan | PRESIDENT AND CEO, Director | $3.03M | Oct 19, 2023 | ||
| Eyal Rubin | Sr. VP and CFO | $932K | Sep 23, 2024 | ||
| Aharon Schwartz | Director | $245K | Sep 29, 2023 | ||
| Yael Hayon | VP, Research & Development | $49.5K | Aug 15, 2023 | ||
| Amos Bar-Shalev | Director | Sep 29, 2023 | |||
| Zeev Bronfeld | Director | Sep 7, 2022 | |||
| Eliot Forster | Director | Sep 14, 2023 | |||
| Zvi Shmuel Ben | Director | Sep 29, 2023 | |||
| Pol F. Boudes | Director | Sep 29, 2023 | |||
| Gwen A. Melincoff | Director | Sep 29, 2023 | |||
| Yaron Naos | Sr. VP, Operations | Sep 23, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|